Summary

We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary methods for qualitative market assessments and market segmentation are top-down and bottom-up techniques. We take pride in our ability to use data triangulation to examine the market from three key angles: primary data mining, a specific statistical model and framework, and primary source data validation.

We carefully choose our original raw market data for analysis from a vast collection of data that has been compiled in our repository, as well as from sets of trustworthy and validated websites, analyst evaluations, news announcements, whitepapers, and reputable paid databases. Trade journals and in-depth surveys are used to collaborate on technical data and trends. Verified sources are used to assess pricing trends and market dynamics.

We use particular data simulation models to get our market estimates and forecasts. These models are developed and tailored to match the unique needs of every study. They are nimble and adaptable. For the most part, we use a joint combination of technological analysis, economic tools, domain experience, and economic techniques to forecast and estimate the market. In general, we favor using a bottom-up method to assess the worldwide market and calculate the anticipated rate of growth.

To verify our hypotheses and the results we have gotten, we carry out in-depth primary interviews, which include phone conversations, in-person discussions, and targeted group discussions. Extensive primary research has been conducted to verify our figures and forecast. These interviews also provide us with an objective view of the market, important information on companies operating in various markets, and up-to-date business scenarios.

Interventional Radiology Imaging Market based on Product:
• MRI Systems
• Ultrasound Imaging Systems
• CT Scanners
• Angiography Systems
• Fluoroscopy Systems
• Biopsy Devices
• Other Products
Interventional Radiology Imaging Market based on Application:
• Cardiology
• Urology and Nephrology
• Oncology
• Gastroenterology
• Other Applications
Interventional Radiology Imaging Market based on Geography:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
This market is divided into product, process, and application segments. This market is predicted to increase as a result of several factors, including rising chronic disease incidence and prevalence, rising desire for minimally invasive procedures, and developments in technology. The market for interventional radiology imaging now has a wide range of potential because to the rising markets. But MRI manufacturers and healthcare institutions are very concerned about the risk of excessive radiation exposure, which is anticipated to limit this market's growth somewhat over the course of the projection period.

The market is divided into categories based on products, including MRI systems, CT scanners, fluoroscopy systems, angiography systems, ultrasound-imaging systems, and other devices (C-arm, contrast media injectors, & imaging catheter guidewires). In 2016, the MRI system category is anticipated to hold the biggest market share. This market is being driven by factors like new product releases and technological advances.

The market is divided into categories based on procedures, including nephrostomy, vertebroplasty, angioplasty, embolization, thrombolysis, and other operations (such as cholecystectomy, carotid-cavernous fistula, fallopian tube recanalization, and biliary drainage). During the projection period, the angiography segment is anticipated to hold the biggest market share. The growing desire for minimally invasive procedures and the rising incidence of cardiovascular illnesses are the main drivers of growth in this market.

The market is divided into several segments based on application, including gastroenterology, neurology, orthopedics, oncology, urology & nephrology, and cardiology. During the course of the projection period, the cardiology sector is anticipated to hold the biggest market share. A few of the elements driving this segment's growth are the demand for interventional radiology procedures.
The market is divided into four geographic segments: North America, Europe, Asia, and the Rest of the World (RoW). Asia, however, is anticipated to have the highest CAGR. In the upcoming years, the market is anticipated to develop due to the increasing incidence and prevalence of chronic diseases, as well as the increased attention of domestic players and industry leaders in this area.

The following companies are major players in the interventional radiology imaging market: Hitachi Medical Corporation (Hitachi Ltd.) (Japan), Fujifilm Corporation (Japan), Samsung Medison (South Korea), Carestream Health, Inc. (U.S.), Esaote S.p.A. (Italy), Hologic, Inc. (U.S.), GE Healthcare (General Electric Company) (U.K.), Siemens Healthcare GmBH (Siemens AG) (Germany), Koninklijke Philips N.V. (The Netherlands), Toshiba Medical Systems Corporation (Toshiba Corporation) (Japan), Hitachi Medical Corporation (Japan).

• This report illustrates the most vital attributes of the Interventional Radiology Imaging Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Interventional Radiology Imaging Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Interventional Radiology Imaging Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Interventional Radiology Imaging Market.

ページTOPに戻る

Table of Contents

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. MRI Systems
5.3. Ultrasound Imaging Systems
5.4. CT Scanners
5.5. Angiography Systems
5.6. Fluoroscopy Systems
5.7. Biopsy Devices
5.8. Other Products
6. Application: Market Size & Analysis
6.1. Overview
6.2. Cardiology
6.3. Urology and Nephrology
6.4. Oncology
6.5. Gastroenterology
6.6. Other Applications
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America (U.S., Mexico, Canada)
7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
7.5. Latin America (Brazil, Argentina)
7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. SAMSUNG ELECTRONICS C LTD
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. GE HEALTHCARE
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. CANON MEDICAL SYSTEM CORPORATION
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. KONINKILIJKE PHILIPS N.V
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. SIEMENS HEALTHINEERS
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. OLYMPUS CORPORATION
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. SHIMADZU CORPORATION
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. FUJIFILM CORPORATION
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. HOLOGIC INC
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. ESAOTE SPA
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy

10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR MRI Systems, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Ultrasound Imaging Systems, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR CT Scanners, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Angiography Systems, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Fluoroscopy Systems, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Biopsy Devices BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 9. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Cardiology, 2021-2030 (USD BILLION)
TABLE 10. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Urology and Nephrology, 2021-2030 (USD BILLION)
TABLE 11. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Oncology, 2021-2030 (USD BILLION)
TABLE 12. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Gastroenterology, 2021-2030 (USD BILLION)
TABLE 13. INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE FOR Other Applications, 2021-2030 (USD BILLION)
TABLE 14. NORTH AMERICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 15. NORTH AMERICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 17. U.S INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 18. U.S INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 19. CANADA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 20. CANADA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 21. MEXICO INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 22. MEXICO INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 23. EUROPE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 24. EUROPE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 25. EUROPE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 26. GERMANY INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 27. GERMANY INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 28. U.K INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 29. U.K INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 30. FRANCE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 31. FRANCE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 32. ITALY INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 33. ITALY INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 34. SPAIN INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 35. SPAIN INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 36. ROE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 37. ROE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 38. ASIA PACIFIC INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 39. ASIA PACIFIC INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 40. ASIA PACIFIC INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 41. CHINA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. CHINA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 43. INDIA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 44. INDIA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 45. JAPAN INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 46. JAPAN INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 47. REST OF APAC INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. REST OF APAC INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. LATIN AMERICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 50. LATIN AMERICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 51. BRAZIL INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 52. BRAZIL INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 53. ARGENTINA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 54. ARGENTINA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 55. MIDDLE EAST AND AFRICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 56. MIDDLE EAST AND AFRICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 57. SAUDI ARABIA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. SAUDI ARABIA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 59. UAE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 60. UAE INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 61. REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 62. REST OF MIDDLE EAST AND AFRICA INTERVENTIONAL RADIOLOGY IMAGING MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 63. SAMSUNG ELECTRONICS C LTD: FINANCIALS
TABLE 64. SAMSUNG ELECTRONICS C LTD: PRODUCTS & SERVICES
TABLE 65. SAMSUNG ELECTRONICS C LTD: RECENT DEVELOPMENTS
TABLE 66. GE HEALTHCARE: FINANCIALS
TABLE 67. GE HEALTHCARE: PRODUCTS & SERVICES
TABLE 68. GE HEALTHCARE: RECENT DEVELOPMENTS
TABLE 69. CANON MEDICAL SYSTEM CORPORATION: FINANCIALS
TABLE 70. CANON MEDICAL SYSTEM CORPORATION: PRODUCTS & SERVICES
TABLE 71. CANON MEDICAL SYSTEM CORPORATION: RECENT DEVELOPMENTS
TABLE 72. KONINKILIJKE PHILIPS N.V: FINANCIALS
TABLE 73. KONINKILIJKE PHILIPS N.V: PRODUCTS & SERVICES
TABLE 74. KONINKILIJKE PHILIPS N.V: RECENT DEVELOPMENTS
TABLE 75. SIEMENS HEALTHINEERS: FINANCIALS
TABLE 76. SIEMENS HEALTHINEERS: PRODUCTS & SERVICES
TABLE 77. SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS
TABLE 78. OLYMPUS CORPORATION: FINANCIALS
TABLE 79. OLYMPUS CORPORATION: PRODUCTS & SERVICES
TABLE 80. OLYMPUS CORPORATION: RECENT DEVELOPMENTS
TABLE 81. SHIMADZU CORPORATION: FINANCIALS
TABLE 82. SHIMADZU CORPORATION: PRODUCTS & SERVICES
TABLE 83. SHIMADZU CORPORATION: DEVELOPMENTS
TABLE 84. FUJIFILM CORPORATION: FINANCIALS
TABLE 85. FUJIFILM CORPORATION: PRODUCTS & SERVICES
TABLE 86. FUJIFILM CORPORATION: RECENT DEVELOPMENTS
TABLE 87. HOLOGIC INC: FINANCIALS
TABLE 88. HOLOGIC INC: PRODUCTS & SERVICES
TABLE 89. HOLOGIC INC: RECENT DEVELOPMENTS
TABLE 90. ESAOTE SPA: FINANCIALS
TABLE 91. ESAOTE SPA: PRODUCTS & SERVICES
TABLE 92. ESAOTE SPA: RECENT DEVELOPMENTS